![f0059-02](https://article-imgs.scribdassets.com/gf64ek9vkbx5bw3/images/file3GCVCG1K.jpg)
![f0059-01](https://article-imgs.scribdassets.com/gf64ek9vkbx5bw3/images/fileFNTAC90A.jpg)
Japan “continues to post economic gains, with a service sector recovery and pent-up demand driving growth”, according to a recent report by global professional services firm Deloitte. An upcoming wage bump and accommodative monetary policy should help support demand through the year. Solid growth, high incomes, and an aging population make Japan the world’s third-largest pharmaceutical market, according to the US International Trade Administration. The country is home to one of the world’s most innovative pharmaceutical sectors, exporting drugs worth $45bn annually.
Osaka-based Shionogi is at the cutting edge of this industry, and is building a global presence. Shionogi aims